Clinical Trials Browser

Lung Diseases, Interstitial × pembrolizumab × Clear all

NCT07420439 2026-02-19

Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease

Phase 2 Not yet recruiting

Lung Diseases, Interstitial

NCT04807114 2024-07-01

A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLC

Lung Diseases, Interstitial